Displaying 1 to 12 of 12 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
Anthera Pharmaceuticals Inc |
United States | N/A Active |
||
![]() |
Aperto Networks Inc WiMax equipment company. |
United States | 3 Oct 2000 | Series B Active |
|
![]() |
CyberHeart Inc Developer of radiosurgical system for cardiac applications |
United States | 1 Jan 2008 | Series A |
|
![]() |
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. |
United States | N/A |
||
![]() |
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
||
![]() |
LigoCyte Pharmaceuticals Inc |
United States | N/A |
||
![]() |
Nanotech Partners I LP Venture capital fund that focuses exclusively on nanotechnology around the world |
Fund Closing Active |
|||
![]() |
ObjectVideo Inc |
United States | N/A |
||
![]() |
Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. |
United States | N/A |
||
![]() |
Shutterfly Inc Shutterfly is a leading Internet-based social expression and personal publishing service. |
United States | 1 Feb 2001 | Series C |
|
![]() |
Teknovus Inc EPON chipsets company that support IPTV-triple-play services via optical fiber networks. |
United States | 1 Aug 2005 | Series C |
|
![]() |
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States | 1 Apr 2010 | Series B |